Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed, often without clear indications. There are conflicting data on its association with mortality risk and hepatic decompensation in cirrhotic patients. Furthermore, PPI users and PPI exposure in some studies have been poorly defined with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: De Roza, Marianne Anastasia, Kai, Lim, Kam, Jia Wen, Chan, Yiong Huak, Kwek, Andrew, Ang, Tiing Leong, Hsiang, John Chen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2019
Aiheet:
Retrospective Cohort Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737311/
https://ncbi.nlm.nih.gov/pubmed/31543684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i33.4933
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia